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Disassembly is a key event of virus entry into cells. Here, we have investigated cellular requirements for the
first step of adenovirus type 2 (Ad2) disassembly, the release of the fibers. Although fiber release coincides
temporally with virus uptake, fiber release is not required for Ad2 endocytosis. It is, however, inhibited by
actin-disrupting agents or soluble RGD peptides, which interfere with integrin-dependent endocytosis of Ad2.
Fiber release occurs at the cell surface. Actin stabilization with jasplakinolide blocks Ad2 entry at extended cell
surface invaginations and efficiently promotes fiber release, indicating that fiber release and virus endocytosis
are independent events. Fiber release is not sufficient for Ad2 escape from endosomes, since inhibition of
protein kinase C (PKC) prevents Ad2 escape from endosomes but does not affect virus internalization or fiber
release. PKC-inhibited cells accumulate Ad2 in small vesicles near the cell periphery, indicating that PKC is
also required for membrane trafficking of virus. Taken together, our data show that fiber release from incoming
Ad2 requires integrins and filamentous actin. Together with correct subcellular transport of Ad2-containing
endosomes, fiber release is essential for efficient delivery of virus to the cytosol. We speculate that fiber release
at the surface might extend the host range of Ad2 since it is associated with the separation of a small fraction
of incoming virus from the target cells.
Adenoviruses (Ads) are among the best-characterized viral
systems (24, 49). Both past and ongoing Ad studies have sig-
nificantly contributed to concepts in molecular and cellular
biology and have facilitated the development of Ad vectors for
preclinical and clinical trials (3). Ads are nonenveloped icosa-
hedral particles of about 90 nm in diameter (8). The main
capsid component is the facette-associated hexon protein,
which is assembled and stabilized by various minor proteins.
Hexon largely protects a double-stranded linear DNA genome,
which is packed inside the capsid together with additional viral
proteins including the cysteine protease L3/p23. The bases of
the capsid vertices are built from the penton base protein from
which fibers emanate. Of the six Ad subgroups, comprising
almost 50 serotypes, the subgroup C viruses such as Ad2 and
Ad5 have been studied the most extensively. It was realized
relatively early that subgroup C Ad entry requires two recep-
tors, a primary receptor, CAR (coxsackie-adenovirus recep-
tor), for attachment (4, 56) and secondary receptors, avb5 or
avb3 integrins, for internalization (62). While the primary re-
ceptor determines virus tropism and is a major aim in current
retargeting studies of Ad (for a recent review, see reference
12), the secondary receptor plays more subtle but less well
understood roles in the infection process. Besides facilitating
virus internalization, most probably via clathrin-coated pits
(41, 58), avb5 integrins contribute to Ad-dependent permeabi-
lization of the plasma membrane (61), activation of phospha-
tidylinositol 3-OH kinase (29), and small G proteins of the Rho
family (28) and the activation of the Raf/extracellular receptor
kinase 1 and 2 (ERK1,2) pathway (6). While the mitogen-
activated protein kinase pathway of ERK1,2 is not required for
Ad entry, activated integrins play a role in virus uptake and
intracellular transport.
Endocytosis of Ad requires integrins, assembly of clathrin-
coated pits, and invagination and fission of the plasma mem-
brane, followed by routing of the emerging vesicle toward early
endosomes. The entire process is regulated by lipid kinases,
actin-modulating small GTPases, and the large GTPase dy-
namin (28, 29). Like Ad endocytosis, integrin-mediated endo-
cytosis is complex and can involve the recruitment of the clath-
rin internalization machinery, dynamin (38, 48), dynamic
rearrangement of cortical actin filaments, and, finally, vesicular
movement through the cell cortex controlled by lipid and pro-
tein kinases and small GTPases (27, 36, 51). Unlike physiolog-
ical extracellular integrin ligands, internalized Ad2 escapes
from acidified endocytic vesicles (5, 41). It is then translocated
as a naked particle along microtubules to the nucleus (54) and
docks at nuclear pore complexes (9), where the capsid is dis-
assembled (20) and the DNA genome is imported into the
nucleoplasm (19).
In contrast to wild-type (wt) Ad2, an Ad2 mutant, ts1, fails to
escape from the endocytic system (33, 60). ts1 has a point
mutation in the L3/p23 protease, preventing protease packag-
ing and proper processing of the viral capsid structure at the
restrictive temperature (for a review, see reference 18). After
passing the cell cortex, ts1 endosomes are transported to a
perinuclear region by microtubule-dependent motors (54) and
ts1 is eventually degraded in lysosomes (20). Part of the reason
why ts1 fails to escape from endosomes could be the failure to
release fibers, although it binds to CAR and internalizes via
integrins much like wt Ad2 (20, 29). Here we have analyzed
cellular requirements for the first step of wt Ad2 disassembly,
the release of the fibers. We show that besides cortical actin
filaments, integrins play a crucial role in detaching fibers at the
cell surface. Following fiber detachment, Ad2 is endocytosed
and transported through the actin cortex in a protein kinase C
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(PKC)-dependent fashion to finally escape from endosomes
and reach the cytosol.
MATERIALS AND METHODS
Cells, viruses, and infections. HeLa cells (American Type Culture Collection)
were grown on glass coverslips or 30-mm-diameter petri dishes in Dulbecco’s
modified Eagle’s medium (DMEM) (Gibco-BRL) containing 7% fetal calf serum
(HyClone) and L-glutamine in a humidified 5% CO2–air atmosphere. In some
experiments, cells were treated for 30 min at 37°C in growth medium with 2 mM
cytochalasin D (CD) (Calbiochem, Juro Supply) 180 nM jasplakinolide (Jas) (a
gift from Phil Crews, Santa Cruz, Calif.), 0.5 mM cyclic arginine-glycine-aspar-
tate peptide (cRGD) (a gift from J. Glass, Telios Pharmaceuticals, San Diego,
Calif.), 1 mM linear arginine-glycine-glutamate-serine peptide (RGES) (Sigma),
the PKC inhibitor calphostin C (5 mM) (Calbiochem, Juro Supply) or bisindolyl-
maleimide (BIM) (5 mM) (Sigma, Fluka), the myristoylated pseudosubstrate of
PKCa and PKCb (10 mg/ml) (Promega, Catalys AG), which inhibits all classical
PKCs, or a control myristoylated autocamptide-related inhibitory peptide (10
mg/ml) (Calbiochem, Juro Supply). The cold-synchronized infection with Ad in
RPMI-bovine serum albumin (BSA) medium containing drugs was followed by a
warming period in DMEM–0.2% BSA containing drugs as indicated.
Ad2 (wt and ts1) were grown, isolated, and labeled with Texas red (TR) or
[35S]methionine as described previously (20, 21, 37, 60). A 0.16-mg sample of
fluorescent virus in 0.25 ml of cold RPMI-BSA was bound to subconfluent HeLa
cells grown on 12-mm glass coverslips (multiplicity of infection [MOI], 400).
Alternatively, 160,000 cpm of [35S]methionine-labeled Ad2 (1.9 3 106 PFU) was
incubated with 3 3 105 HeLa cells in cold RPMI (MOI 6). Cells were washed,
incubated with warm DMEM-BSA for various times, chilled in cold PBS, and
treated with trypsin (2 mg/ml; Gibco-BRL) for 1 h in the cold as described earlier
(21). After inactivation of trypsin, cells were lysed in 0.5 ml of 0.5% Empigen BB
(Calbiochem, Juro Supply) in MNT buffer (0.02 M 2-N-morpholinoethansulfonic
acid, 0.1 M sodium chloride, 0.03 M Tris-HCl) (pH 7.5) containing 0.001 M
EDTA and the protease inhibitors 0.5 mM phenylmethylsulfonyl fluoride
(Bo¨hringer, Mannheim, Germany), 0.5 mM benzamidine (Fluka), 0.001 mg of
leupeptin (ICN Biomedicals GmbH) per ml, 0.001 mg of chymostatin (Bo¨hr-
inger) per ml, and 0.001 mg of pepstatin (Fluka) per ml (21). An aliquot of the
lysate was precipitated with trichloroacetic acid, dissolved in sodium dodecyl
sulfate (SDS) sample buffer, and analyzed for intact and trypsin-cleaved hexon by
SDS-polyacrylamide gel electrophoresis (PAGE) and PhosphorImager analysis
(Molecular Dynamics, Bucher AG) using National Institutes of Health Image
software for quantification (http://rsb.info.nih.gov/nih-image/index.html). The
ratio of cleaved to uncleaved hexon is an indication of the cell surface accessi-
bility of Ad2 and usually correlates with virus internalization (21).
To analyze the extent of fiber association with viral capsid, cells were lysed in
Empigen-MNT buffer and fiber antigens were collected by incubating the lysate
with an immunoglobulin G fraction of the polyclonal antifiber antibody R72 (5
mg/ml) (2) and Zysorbin (Zymed, Ma¨chler AG). Immunocomplexes were
washed, fractionated by SDS-PAGE, and analyzed by PhosphorImager analysis.
The ratio of [35S]methionine in hexon to that in fiber was taken as a measure of
the number of fiber-containing Ad capsids (21).
Quantitative fluorescence microscopy. Cell-associated Ad2-TR was quanti-
tated in the cell periphery, in the cytoplasm, and at the nucleus as described
previously (37). In brief, HeLa cells were infected with Ad2-TR, fixed with 3%
paraformaldehyde in phosphate-buffered saline, permeabilized for 2 min with
0.5% Triton X-100 in phosphate-buffered saline including 20 mM ammonium
chloride to reduce autofluorescence, and stained for the nuclear DNA with
4,6-diamidino-2-phenylindole (DAPI) (0.5 mg/ml) (Sigma), and for the plasma
membrane Ca-ATPase 1 with an affinity-purified antibody kindly provided by D.
Guerini (ETH Zurich) (53) and goat anti-rabbit immunoglobulin G coupled to
Alexa 488 (Molecular Probes, Leiden, The Netherlands). Specimens were em-
bedded in 0.2% p-phenylendiamine–0.02 M Tris-HCl–85% glycerol (pH 8.8) and
analyzed by fluorescence microscopy using an inverted motorized Leica
DMIRBE microscope equipped with a 1003 objective (N.A. 1.3 PL Fluotar) and
a back-illuminated MicroMax-controlled charge-coupled device camera (800 by
1,000 pixels of 15 by 15 mm [Princeton Instruments, Visitron GmbH]), which was
operated in 16-bit mode at 225°C. Excitation occurred through band-pass exci-
tation filters for DAPI (330/80; Omega XF03), Alexa 488 (475/40; Omega
XF100), and TR (560/55; Omega XF101), and emitted light was collected either
through a single-pass (DAPI, 425LP, dichroic 400; Omega XF03) or a double-
pass (green and red, 528/30 and 633/60; dichroic 490/575; Omega XF53) emission
filter. The TR images were recorded sequentially throughout the entire cell
sample (z-stack) at 1-mm steps. Alexa 488, DAPI, and differential interference
contrast images were obtained from sections toward the cell bottom or the
middle to indicate cell and nuclear dimensions, respectively. Each TR image was
processed by fast Fourier transformation (FFT) to remove out-of-focus infor-
mation and to correct for uneven illumination as described previously (37).
FFT-processed images were merged using the summation function, and back-
ground was subtracted by setting the lowest pixel value to 0. Pixel values of TR
were determined in regions of interest, which were defined by a thresholding
function using the plasma membrane and the nuclear strains, respectively.
CLSM. Confocal laser-scanning microscopy (CLSM) was performed with a
confocal unit (TCS SP; Leica), on an inverted microscope (Leica DMIRBE)
using the 633 lens (N.A. 1.32). Optical sections were collected at step sizes of 0.5
mm. For DAPI imaging, a UV laser with excitation lines at 351 and 364 nm was
used. For detection of the emission, the spectrophotometer was set to 410 to 530
nm. The plasma membrane marker Ca ATPase 1 was visualized by indirect
immunofluorescence using an Alexa 488-tagged secondary antibody. Alexa 488-
and TR-coupled Ad2 were recorded with the 488- and 568-nm laser lines of an
argon/krypton laser, respectively. The settings of the spectrophotometer were
495 to 560 nm for Alexa 488 and 580 to 640 nm for TR. The pinhole for all
recordings was set to 1.0. Images of the three fluorochromes were taken sequen-
tially to exclude cross talk between the channels.
EM. Electron microscopy (EM) was carried out as described previously (54).
For quantification, micrographs were recorded in sections across the middle of
the cells by a slow-scan charge-coupled device camera (Gatan, Gloor AG) at
330,000 magnification using the DigitalMicrograph software package (version
3.3.1; Gatan, Pleasanton, Calif.). Morphometry of single sections from 11 to 14
randomly selected entire cells was carried out for each of the drug conditions as
specified. All the cell-associated virus particles were quantitated. This required
90 to 179 micrographs depending on the number of virus particles present in the
analyzed cells.
Statistics. Statistical analyses were conducted using a one-sided t test with
indicated confidence intervals, standard error of the mean (SEM), and sample
size (n).
RESULTS
Dissociation of the fibers from the capsid is the first event in
the stepwise uncoating program of Ad2 (21). Although it co-
incides with virus endocytosis, the cellular requirements or
functional implications are unknown.
Cellular requirements for fiber release. Since Ad uptake
into cells requires an intact actin cytoskeleton and is facilitated
by av integrins (28, 42), we first analyzed whether filamentous
actin (F-actin) and integrins were implicated in fiber release
from incoming Ad2. To disrupt actin filaments, HeLa cells
were treated with CD, which caps F-actin, stimulates ATP
hydrolysis on globular actin, and also affects the small G pro-
tein rho A (44, 47). Alternatively, cells were incubated in low
concentrations of Jas, which binds to and stabilizes F-actin in a
similar fashion to the cell-impermeable phalloidin (7, 11). The
efficiency of CD in disrupting F-actin and the ability of Jas to
bind to F-actin were examined by staining cells with phalloidin-
Alexa 488 following fixation with paraformaldehyde and per-
meabilization with Triton X-100. Jas-treated cells showed no
phalloidin staining at all, although stress fibers and cortical
actin were readily visualized using anti-actin antibodies (data
not shown). CD-treated cells contained large amounts of phal-
loidin-positive actin aggregates. To measure fiber release,
[35S]methionine-labeled Ad2 was bound to drug-treated cells
in the cold and internalized at 37°C for 0, 15, or 30 min.
Immunocomplexes containing fiber epitopes were collected
from Empigen-lysed cells using a specific antifiber antibody
(R72,2), which recognizes intact Ad2 particles (21). The
amounts of immunoadsorbed [35S]methionine-labeled fiber
and coprecipitated hexon were quantitated by SDS-PAGE and
PhosphorImager analysis as described earlier (21). The hexon-
to-fiber ratio derived from intact [35S]methionine-labeled virus
(not incubated with cells) was set to 100% (Fig. 1, lane 1). As
expected, control cells efficiently promoted the dissociation of
fiber from hexon within 30 min (more than sixfold) and with a
half-maximal efficiency at 12 min postinfection (p.i.) (lanes 2 to
4). In contrast, fiber dissociation from hexon was slowed in
CD-treated cells, reaching half-maximal efficiencies after 30
min of warming (lanes 5 to 7). However, no delay of fiber
release was detected in infections in Jas-treated cells (lanes 8
to 10), suggesting that fiber release is promoted by an intact
rather than dynamic F-actin cytoskeleton. We then asked if
integrins were directly or indirectly involved in triggering fiber
release. Cells were incubated with cRGD peptides or control
RGE peptides to inhibit Ad2 endocytosis (1, 62), and fiber
dissociation was determined as described above. The results
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demonstrated that cRGD peptides were efficient inhibitors,
since control RGE peptides had no effect on fiber release
(lanes 11 to 16). The data showed that fiber release correlated
with virus uptake and required an intact actin cytoskeleton.
Fiber release occurs at the cell surface. To test if Ad uptake
was required for fiber release from incoming capsids, we ex-
amined Ad2 endocytosis by three different assays, a biochem-
ical cell surface trypsinization assay, a quantitative combined
CLSM-fluorescence microscopy assay, and quantitative EM. In
the first assay, [35S]methionine-labeled Ad2 was bound to CD-
or Jas-treated cells and the amount of trypsin-resistant hexon
was determined at different times of infection (21). Since this
assay measures the trypsin accessibility of the major capsid
protein hexon at 4°C, it estimates the amount of protease-
sensitive virus on the cell surface. Note, however, that the
trypsinizations did not remove virus particles from control cells
(Fig. 2A, and D), although the hexons were quantitatively
cleaved at the potential trypsin cleavage sites in loop 1 near the
N terminus (26). Using this assay, typical times for half-maxi-
mal Ad2 internalization (t1/2) into control cells were around 10
to 12 min and efficiencies were near 80% at 60 min p.i. (Fig. 2A
and G). Disruption of the actin cytoskeleton by CD, however,
completely blocked the appearance of trypsin-resistant hexon
up to 60 min p.i. (Fig. 2B and G), consistent with earlier results
(28).
These results were in agreement with CLSM data demon-
strating that fluorescent Ad2-TR did not effectively reach the
nuclei of CD-treated cells up to 60 min p.i. (Fig. 3C, whole en
face projections). In control cells, Ad2-TR was efficiently trans-
located to the nucleus at 60 min but not at 0 min p.i. (Fig. 3A
and B). We have quantitated fluorescent Ad2 by using an FFT
image-processing routine described earlier (37). Ad2-TR near
the cell periphery, the cytoplasm, and the nuclei of control or
CD-treated cells was determined at 0 and 70 min p.i. (Fig. 4A).
In control cells, the fraction of Ad2-TR in the periphery de-
creased about fivefold (P , 0.01), but in CD-treated cells it was
only slightly reduced (P 5 0.025). Conversely, the CD-treated
cells contained more Ad2-TR in both the peripheral and the
cytoplasmic areas (P , 0.01) but much less virus in the nuclear
area (P , 0.01) compared to the control cells at 70 min p.i.
EM confirmed that Ad2 was largely excluded from the cy-
toplasm and enriched at the plasma membrane of CD-treated
cells at 30 min p.i. and was typically associated with plasma
membrane extensions (Fig. 5). Quantifications of electron mi-
crographs indicated that only 4% of the cell-associated Ad2
particles were found in the cytoplasm of these cells and 6%
were in intracellular vesicles, compared to 31% cytoplasmic
(P , 0.01) and 11% vesicular (P 5 0.1) in control cells (Fig. 6A
and B). Note that in CD-treated cells all the vesicular virus
particles were found in small vesicles with diameters less than
200 nm and 90% of the particles were associated with the
plasma membrane compared to 58% in control cells (P ,
0.01). The levels of extracellular Ad2 in the control cells at 30
min p.i. were about twice as high as in the low-MOI infections
using [35S]methionine-labeled Ad2 (Fig. 2) suggesting that the
Ad2 uptake system is saturated in the high-MOI EM experi-
ments. Interestingly, 7% of the viruses at the surface of CD-
treated cells were associated with coated pits compared to 13%
in control cells (P 5 0.025), indicating that CD did not block
the formation of clathrin-coated pits containing Ad2, in agree-
ment with earlier studies on Semliki Forest virus entry (30).
A different picture emerged for Jas-treated cells, where
[35S]methionine labeled Ad2 became rapidly resistant to sur-
face trypsinization, with half-maximal efficiencies at 10 min p.i.
and overall efficiencies of nearly 80% at 60 min p.i., similar to
control cells (Fig. 2C and G). However, unlike control cells, the
Jas-treated cells did not dissociate Ad2 from their surface, as
indicated by the total amount of cell-associated hexon protein
(Fig. 2G). It is possible that either enhanced endocytosis pre-
cluded virus shedding to the medium or Ad2 became trapped
FIG. 1. Fiber release from incoming Ad2 depends on intact F-actin and is inhibited by RGD peptides but not PKC inhibitors. HeLa cells were treated with the
indicated inhibitors for 30 min at 37°C and then incubated with [35S]methionine-labeled Ad2 in the cold for 1 h and warmed for different times as indicated. Cell lysates
were immunoprecipitated with antifiber antibodies under nondissociating conditions and fractionated by SDS-PAGE. [35S]methionine in hexon (Hex) and fiber (Fib)
was quantitated and expressed as a ratio of hexon to fiber by using purified [35S]methionine-labeled Ad2 as a standard (100%). The data are representative of at least
two independent experiments.
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in plasma membrane structures prior to endocytosis. To dis-
tinguish between these two possibilities, we analyzed the entry
of Ad2-TR into Jas-treated and control cells by CLSM. The
data suggested that Ad2-TR remained near the periphery of
Jas-treated cells at 60 min p.i. (Fig. 3D). Little nuclear Ad2-TR
was detected in these cells at 60 min p.i. (Fig. 3). Quantifica-
tions of Ad2-TR fluorescence in different subcellular regions
indicated that the differences in Ad2-TR levels in both the
periphery and the cytoplasm of Jas-treated cells compared to
control cells were highly significant at 70 min p.i. (P , 0.01)
(Fig. 4A). Likewise, the differences in nuclear fluorescence
were highly significant at 70 min p.i. (P , 0.01). Interestingly,
peripheral Ad2-TR in the Jas-treated cells was slightly lower at
70 min p.i. than at 0 min p.i. (P , 0.01) and was somewhat
increased in the nuclear region at 70 min p.i. compared to 0
min (P , 0.01).
To test if the inhibition of nuclear targeting by Jas was leaky
or, alternatively, if the cell surface structure was altered by Jas
treatment, we used EM to analyze the subcellular localization
of Ad. As indicated in Fig. 5, many cell surface invaginations
were detected in Jas-treated cells (Fig. 5B, arrows). These
invaginations often (but not always) contained Ad particles
and were also found in noninfected Jas-treated HeLa cells
(data not shown). A quantitative analysis of Ad2 particles in
randomly selected Jas-treated cells indicated that 85% of the
virus particles were at the extracellular face of the plasma
membrane, 10% were within intracellular vesicles, and 5%
were in the cytosol, even though these cells displayed trypsin
resistance of the viral hexon protein (Fig. 6C). In contrast, 58
and 31% of particles were found extracellularly and in the
cytoplasm of control cells (Fig. 6A). Interestingly, in Jas-
treated cells, 33% of the particles were within extended surface
invaginations, 49% were on smooth plasma membrane regions,
and 3% were in coated-pit-containing plasma membrane do-
mains. Compared to the values for control cells, these numbers
were highly significant (P , 0.01) and were in full agreement
with a reduced infection of Jas-treated cells (data not shown).
Collectively, the data indicated that Jas blocked Ad2 uptake
but still allowed efficient fiber release from the particles, im-
plying that fiber release occurs at the cell surface indepen-
dently of endocytosis.
Fiber release is not sufficient for virus escape from endo-
somes. Vitronectin is a physiological ligand of the Ad corecep-
tor avb5 integrin (39). Endocytosis of a conformationally al-
FIG. 2. Cell surface trypsinization assay of incoming [35S]methionine-labeled Ad2 in cells treated with actin and PKC inhibitors. HeLa cells were treated with
various inhibitors for 30 min, and then [35S]methionine-labeled Ad2 was bound for 60 min in the cold. The cells were warmed for different times as indicated and treated
with cold trypsin to probe for surface accessibility of hexon. The ratio of intact (Hex) to cleaved (Hex9) hexon was determined after SDS-PAGE (A to F) and plotted
for each condition, taking the sum of the cleaved and uncleaved hexons from cells not treated with trypsin (2T) as 100% (G and H). Controls not treated with trypsin
are shown in panels A, B, D, and F. Dashed lines in panels G and H indicate the total hexon radioactivity, and solid lines show the trypsin-resistant hexon determined
by PhosphorImager analysis. Symbols for different drug treatments are used as indicated in panels G and H. Representative data from at least two independent
experiments are shown.
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tered vitronectin has been reported to be avb5 integrin
dependent, and subsequent vitronectin degradation in lyso-
somes requires PKC (40). We therefore asked if HeLa cells
treated with PKC inhibitors were able to induce fiber release
from Ad2 and deliver Ad2 to the cytosol. As indicated in Fig.
1 (lanes 17 to 22), the PKC effector site inhibitor calphostin C
or a competitive inhibitor for the ATP binding site BIM had no
drastic effect on the efficiency of fiber release from [35S]me-
thionine-labeled Ad2, although both drugs slightly lowered the
rate of fiber release. Likewise, the PKC inhibitors did not
significantly affect the efficiency of Ad2 uptake at 30 min p.i.,
although they slightly reduced the internalization rate mea-
sured by the trypsin cleavage assay (Fig. 2D to F). Interest-
ingly, the total amount of Ad2 associated with PKC-inhibited
cells decreased to about 60% at 60 min p.i. whereas control
cells contained 85% of the originally cell-bound virus (Fig.
2H). This loss of cell-associated virus was most probably not
due to intracellular degradation, since we did not detect any of
the typical hexon proteolysis products due to lysosomal degra-
dation (20). It is possible that Ad2 was endocytosed and then
delivered back to the surface, where it was removed by trypsin
as originally described for ts1 Ad2 (20).
To test if PKC was required for Ad escape from endosomes,
we treated HeLa cells with a third PKC inhibitor, an N-termi-
nally myristoylated pseudosubstrate of PKCa (PKC-myr) (14),
infected cells with Ad2 at high MOI for 30 min, and subjected
them to EM analysis (Fig. 5D). The quantitated data indicated
that 34% the virus particles found in PKC-myr-treated cells
were located within vesicles compared to 11% in control cells
(P , 0.01) (Fig. 6D). Correspondingly, the levels of cytosolic
Ad2 were significantly reduced (14%) compared to those in the
control cells (31%) (P , 0.01). As expected from the biochem-
ical data (Fig. 2), the amounts of extracellular virus particles
were not significantly different in control and PKC-inhibited
cells (58 and 52%, respectively) and the numbers of Ad2 in
plasma membrane invaginations and coated pits were compa-
rable to those in control cells (P 5 0.1). Similar results were
obtained with other PKC inhibitors, such as calphostin C and
BIM (data not shown). Our results are consistent with the
notion that PKC inhibition had no severe effect on Ad2 endo-
cytosis but inhibited Ad escape from endosomes. A close in-
spection of electron micrographs of PKC-inhibited cells re-
vealed that half of the intracellular particles (vesicular plus
cytosolic Ad2), namely, 24% of all the cell-associated Ad2,
were located within vesicles smaller than 200 nm (Fig. 6D),
reminiscent of endocytic transport vesicles (22).
To address the possibility that PKC inhibition affected the
intracellular transport of Ad2-containing vesicles, we deter-
mined the subcellular location of fluorescently labeled Ad2-
TR. CLSM analysis at 60 min p.i. suggested an inhibition of
nuclear transport of wt Ad2 (Fig. 3E). Quantitative subcellular
analysis of Ad2-TR indicated that PKC-myr decreased Ad
transport from the periphery to the cytoplasm and also to the
nucleus at 60 min p.i. (Fig. 4B) (P 5 0.05). The amounts of
Ad2 in the cytoplasmic area were not affected by PKC inhibi-
FIG. 3. CLSM analysis of incoming Ad2-TR in cells treated with actin and
PKC inhibitors reveals the actin and PKC requirements for nuclear transport of
Ad2. TR-labeled Ad2 (red) was bound to HeLa cells pretreated with drugs or not
pretreated and internalized for 0 min (A) or 60 min (B to E) as indicated in
Materials and Methods. CLSM sections sampling the entire cell were generated
for the TR channel and the Alexa 488 channel (plasma membrane Ca ATPase 1
[green]) and projected en face. The limits of the nucleus as determined by DAPI
staining (results not shown) are indicated by a white trace. A single representa-
tive cell for each of the conditions is shown.
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tion and remained in the same range as those observed at 0
min p.i. The effects of PKC-myr were specific since a myris-
toylated pseudosubstrate for calmodulin (Cam) kinase II (au-
tocamptide [25]) had no effects on the transport of wt Ad2
(Fig. 4B).
To further test if PKC was specifically required for transport
of endosomal Ad2, we analyzed the subcellular localization of
mutant Ad2 ts1, which is known to remain in the endocytic
system (33). ts1-containing vesicles are transported to a perinu-
clear region by microtubule-dependent motors, but ts1 does
not escape or bind to the nuclear envelope (37, 54). Results in
Fig. 4C indicate that PKC inhibition decreased the clearance of
ts1 from the cell periphery (P 5 0.025) but had no effect on ts1
transport to or from the cytoplasmic and nuclear regions. Cy-
toplasmic and nuclear levels of ts1 in PKC-inhibited cells were
not significantly different from the levels at 0 min p.i. (Fig. 4C).
Surprisingly, autocamptide inhibition of Cam kinase II en-
hanced the clearance of ts1 but not wt Ad2 from the cell
periphery (P , 0.01). Since autocamptide did not affect the
cytoplasmic and perinuclear levels of ts1 and since ts1 is known
to cycle from an endocytic compartment back to the surface
even in control cells (20), the data might suggest that Cam
kinase II is involved in the transport of ts1 vesicles in the
periphery. Additional studies are, however, needed to clarify
the precise role of Cam kinase II in Ad entry. Taken together,
our data showed that PKC is not involved in fiber release and
FIG. 4. Quantitative subcellular analysis of incoming fluorescently labeled wt Ad2 and ts1 Ad2 in cells treated with actin- or PKC-directed inhibitors. Ad2-TR was
cold bound to inhibitor-treated or control HeLa cells and internalized for 0 min (open bars) or 60 or 70 min (solid bars) as described in Materials and Methods. The
cells were fixed and analyzed for virus fluorescence in the cell periphery, the cytoplasm, and the nucleus by using an image deconvolution routine described previously
(37). Results are shown as mean fluorescence values, with the corresponding SEM derived from the indicated number of analyzed cells (n). (A) Results for wt Ad2-TR
in actin-inhibited cells. (B and C) Results for wt and ts1 Ad2-TR in cells not treated with drugs (solid bars) or treated with the PKC inhibitor PKC-myr (stippled bars)
or a control myristoylated autocamptide (autocamp) directed against Cam kinase II (striped bars).
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virus endocytosis but is specifically required for transport of
endosomal Ad2-containing vesicles in the periphery. Possibly,
the transport deficiency of PKC-inhibited cells is the underly-
ing reason for the failure of Ad2 to escape from endosomes.
Alternatively, PKC might activate a cell-based membrane lysis
machinery.
Fiber release correlates with virus shedding from the target
cell. In cold-synchronized infections, Ad2 internalization coin-
cides with the shedding of 15 to 20% of the cell-bound virus
particles into the medium (21). To ask if virus shedding cor-
related with fiber release, we overexpressed dominant negative
dynamin I K44A, which has a reduced rate of GTP hydrolysis
affecting both clathrin- and non-clathrin-dependent endocyto-
sis (13, 48) including Ad uptake and gene expression (58).
K44A or wt dynamin I expression was induced by derepressing
a transfected HeLa cell line for 4 days in tetracycline-free
medium (13). The cells were then incubated with TR-labeled
wt Ad2 for 1 h in the cold and warmed for 5 or 60 min. Cells
overexpressing dominant negative dynamin were identified by
the lack of internalized transferrin-Alexa 488, which was
present during the warming period at 100 mg/ml. With this
assay, we found that about 40% of the K44A dynamin I-trans-
fected cells actually overexpressed the K44A mutant protein
(data not shown). Total cell-associated Ad2-TR was then
quantitated in single cells by fluorescence microscopy (37). At
5 and 60 min p.i., control cells expressing wt dynamin con-
tained an average of 23 and 17 TR fluorescence units, respec-
tively (Fig. 7A). The difference was significant (P 5 0.05) and
was in good agreement with earlier results measuring the dis-
sociation of radiolabeled Ad2 particles from cells (21). In
contrast, K44A dynamin-expressing cells contained similar
amounts of Ad2-TR at 5 and 60 min p.i., namely, 12.4 and 10.7
fluorescence units per area (Fig. 7A). Likewise, there was no
difference in the amount of cell-associated Ad2-TR on RGD
peptide-incubated cells at 5 or 60 min p.i., suggesting that
integrins are involved in the shedding of Ad2 (data not shown).
FIG. 5. Thin-section electron microscopy of wt Ad2-infected HeLa cells treated with actin- or PKC-directed inhibitors. Cells were treated with drugs as described
in Materials and Methods and incubated with 50 mg of purified Ad2 per ml for 60 min in the cold. Unbound virus (approximately 98 to 99% of input virus) was washed
off, and the cells were incubated with or without inhibitors for 30 min at 37°C, fixed, and processed for thin-section EM. (A) control cell infected without drugs. (B)
CD-treated cell. (C) Jas-treated cell. (D) PKC-myr-treated cell. The inset in panel D shows an enlargement of a region proximal to the plasma membrane. Thin arrows
indicate extracellular Ad2 particles, large arrows indicate cytoplasmic Ad2, small arrowheads show coated vesicles containing Ad2 (A) and also Ad2 particles within
small vesicles (D), and the large arrowhead depicts Ad2 within a medium-sized vesicle (D), while p indicates a large vesicle (D). Note the enrichment of Ad2 particles
in plasma membrane invaginations of cells treated with the actin stabilizer Jas (C) and the localization of Ad2 within small vesicles of PKC-myr-treated cells (D). Bar
5 500 nm.
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Importantly, the mutant ts1 was not dissociated from wt or
K44A dynamin-expressing cells (Fig. 7B), consistent with its
failure to release fibers upon entry (20). Together, the data
suggested that Ad2 shedding from the target cells required
functional endocytosis and correlated with fiber release.
DISCUSSION
Despite ongoing progress in elucidating virus cell interac-
tions, there are still major deficits in our understanding of Ad
biology, including entry and disassembly of the capsid. In this
study we have analyzed cellular factors involved in the initial
step of Ad2 disassembly, the release of the fibers. Fiber release
is a hallmark of the stepwise Ad disassembly program culmi-
nating in the dissociation of the capsid and the release of the
viral DNA into the nucleoplasm (21, 55).
Surface events for fiber release. We show here that fiber
release requires an intact actin cytoskeleton and proper con-
tacts of the incoming capsid to cell surface integrins but is
independent of virus endocytosis. Fiber release from incoming
Ad2 capsids occurs at the plasma membrane following attach-
ment of the distal fiber knob domains of virus to the surface
receptor CAR (4, 15). The proximal fiber region is anchored in
the capsid via the vertex protein penton base. While Ad2
binding to CAR occurs independently of physiological temper-
atures, fiber release requires warming of the cells and proper
contacts of the penton base protein with cell surface integrins.
These contacts can be inhibited by soluble RGD peptides or
the calcium chelator EGTA inhibiting Ad2 endocytosis (19, 20,
62). These treatments also inhibit fiber release, suggesting that
integrin contacts with the penton base in the context of CAR-
FIG. 6. Quantification of Ad2 particles at the plasma membrane, in intracel-
lular vesicles, and in the cytoplasm of HeLa cells treated with actin- and PKC-
directed drugs or not treated. HeLa cells were infected and analyzed by thin-
section EM as in Fig. 5. (A) Control cells. (B) CD-treated cells. (C) Jas-treated
cells. (D) PKC-myr-treated cells. Viruses were counted in smooth (sh), invagi-
nated (iv), and coated-pit (cp) regions of the plasma membrane, within small (s),
medium (m), or large (l) vesicles, and also in the cytosol (solid bars). The number
of Ad particles on the entire plasma membrane (open bars) and within the entire
vesicle population (striped bars) is also indicated (tot). Mean values are ex-
pressed as the percentage of total virus particles, and the corresponding SEM
values are indicated based on the analyzed number of cells (ranging from 11 to
14) and virus particles (ranging from 339 to 607). The corresponding number of
electron micrographs (ranging from 90 to 179) is also indicated for each of the
conditions.
FIG. 7. Dissociation of Ad2 from target cells requires functional dynamin. wt
or ts1 Ad2-TR was bound in the cold to HeLa cells expressing either wt dynamin
I (wt) or the GTP hydrolysis-defective K44A dynamin mutant. Following warm-
ing for 5 min (open bars) or 60 min (solid bars), cells were fixed and the
cell-associated TR fluorescence was determined by FFT as described earlier (37).
Results are expressed as mean values normalized to the corresponding cell areas
including the SEM and the number of cells analyzed (n).
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bound virus can trigger the dissociation of fibers. It is possible
but unlikely that the penton base is released together with
fibers, since the penton base but not the fiber was detected by
indirect immunofluorescence and cryoimmuno-EM on Ad par-
ticles near the nuclear envelope (data not shown). That the
underlying actin cytoskeleton is also instrumental for fiber
release is indicated by the strong inhibition of fiber release in
cells treated with actin-destabilizing agents, including CD and
latrunculin B (data not shown).
Earlier studies indicated that fiber release coincides with
virus internalization (21). These results and our present data
showing that fiber release occurs in the absence of virus inter-
nalization, e.g., in cells treated with the actin-stabilizing drug
Jas, clearly establish that the trigger for fiber release occurs at
the cell surface. Virus binding to the primary receptor CAR
alone is unlikely to trigger fiber release, since fiber release can
be effectively prevented by conditions which inhibit proper
contacts of virus with av integrins without affecting virus bind-
ing to CAR. CAR may, however, be required to hold the virus
particle in a proper position, allowing av integrins to contact
the penton base. CAR and integrins may in fact synergize the
efficiency of infection, as suggested by fiber swap experiments
where the fiber of a slowly infecting subgroup B virus (Ad7)
was transferred to a quickly infecting subgroup C virus particle
(Ad5). The result was somewhat surprising in that the chimeric
particle now had the slow nuclear transport characteristics of
the subgroup B particles (34). Analysis of whether fiber was
released from the chimeric particles and particles had escaped
to the cytosol will be interesting. In any case, fiber release is
expected to generate particles which are infectious provided
that they attach to a suitable receptor, as suggested by exper-
iments with fiberless Ad2 particles infecting integrin-positive
monocytic cells (57). Soluble avb5 integrin fragments have
been visualized as diffuse densities in cryoelectron micrographs
of isolated Ad2 (32), but it is not clear if integrins play a direct
or an accessory role in triggering fiber release and internaliza-
tion.
Consistent with earlier studies with SW480 cells (28), our
inhibition experiments with HeLa cells using the actin stabi-
lizer Jas confirmed that filamentous or growing actin alone did
not support Ad2 endocytosis. In contrast to CD, which depoly-
merizes F-actin by decreasing the rate of actin growth at the
barbed end of the filament and also severs filaments, Jas po-
tently induces de novo actin nucleation and polymerization,
decreasing monomeric actin and lowering the dynamics of
actin filaments (7). Both inhibitors blocked Ad2 endocytosis in
several different cell types, indicating that filamentous actin
plays an obligatory role in Ad2 endocytosis. Interestingly, Ad2
was trapped in extensive plasma membrane invaginations of
Jas-treated cells (Fig. 5). Similar cell surface changes were also
observed in noninfected polarized cells treated with Jas (50).
Viruses in these invaginations were not accessible to the ex-
tracellular trypsin used in standard internalization assays (21).
Only direct analysis of the infected cells by quantitative EM
and measurements of infectivity revealed the effect of Jas on
Ad infection. Although CD and Jas were almost equally effec-
tive at restricting Ad2 entry at the surface, Jas-treated cells
showed some apparent nuclear transport of fluorescent Ad2
(Fig. 4). This was most probably not due to intracellular Ad2
transport but, rather, was caused by cell contraction in re-
sponse to Jas treatment. Notably, CD caused cell contraction
as well, but this contraction occurred much faster than with Jas
treatment and was essentially complete after the preincubation
period before Ad2 was added to the cells.
While a disrupted actin cytoskeleton did not allow fiber
release, filamentous or growing actin (Jas treatment) sup-
ported fiber release at the cell surface. This event was associ-
ated with the shedding of 15 to 25% of the initially bound Ad2
particles to the medium. It was unlikely that the shed particles
had incorrectly attached to the cell surface, since virus binding
to HeLa cells was inhibited by more than 95% on preincuba-
tion with soluble fiber knob. About half of the released capsids
were able to bind to and infect new target cells, but the rest did
not bind back to CAR-positive cells, suggesting that these
particles had lost most of their fibers. Virus shedding to the
medium was completely blocked by overexpression of the dom-
inant negative dynamin I mutant (K44A), which inhibits both
clathrin- and caveola-dependent endocytosis and might also
affect intracellular transport of vesicles (48). Possibly, K44A
dynamin expression interfered with integrin transport to the
cell surface or alternatively altered the affinity of cell surface
receptors for Ad2, by analogy to observations with epidermal
growth factor receptor and epidermal growth factor (45).
Relevance of fiber release. Fiber shedding at the cell surface
may have several functions. The first function could be to
promote capsid internalization independently of the primary
receptor CAR or perhaps of major histocompatibility complex
class I (4, 23, 56). It is not known whether the CAR receptor
has the capacity to internalize, but the intracellular CAR do-
main is not required for infection (59). However, this does not
exclude the notion that CAR remains permanently at the
plasma membrane. Ad2 ts1 mutants bound to CAR-positive
HeLa cells can be internalized without the apparent loss of
fibers, indicating that fiber release is not required for interac-
tion with an internalization receptor (20). Another reason why
Ad2 would want to release its fibers at the surface could be to
shed particles from a target cell and thus have the potential to
infect neighboring cells expressing a different set of cell surface
receptors. Fiber release is also associated with the ability of
incoming Ad to escape from endosomes, as indicated by the
results with the ts1 mutant, which fails to release fibers but
enters by an integrin-dependent pathway (20, 29, 33). The
reason for the failure of ts1 to release its fibers is not clear.
Possibly, there are multiple contact sites between integrins and
the penton base, one for uptake and another perhaps for fiber
release. Alternatively, ts1 might fail to release its fibers due to
its nonprocessed capsid structure or because it lacks contacts
with unknown surface molecules.
PKC is required for vesicular trafficking and Ad escape
from endosomes but not fiber release. Following fiber release,
Ad is internalized by an integrin dependent pathway. Although
fiber release per se is not required for internalization it may be
required for capsid escape from endosomes. Carboxylic iono-
phores or primary amines neutralizing the acidic pH of intra-
cellular compartments have no effects on the efficiency and the
kinetics of fiber release (21), but they inhibit Ad escape from
endosomes if the virus is present at low MOI (17, 46), suggest-
ing that fiber release is not sufficient for Ad2 escape from
endosomes. In contrast to pH-neutralizing procedures, inhibi-
tion of cellular PKCs was an effective treatment to limit Ad2
escape from endosomes even when Ad2 was present at high
MOI. Given the observations that av integrins contribute to
Ad-mediated release of cytosolic contents (61) and PKC can
be a downstream effector of av integrins (38), it is possible that
combined signaling of integrins and PKC activates a mem-
brane lytic function effecting Ad release to the cytosol. Alter-
natively, but not exclusively, Ad2-mediated endosome lysis
may require PKC-dependent trafficking of virus-containing en-
dosomes and may be related to proper endosome acidification,
which can be increased by PKC stimulation (63). This scenario
would be in agreement with earlier studies suggesting that
subgroup C Ads escape from a mildly acidic compartment,
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possibly the tubulovesicular early endosomal compartment (5,
22, 41), and that membrane trafficking in the cell periphery can
be limited by the cortical actin cytoskeleton (16, 31, 35). Con-
sistently, the early endosomal marker rab5 has been suggested
to interact with actin filaments (36) and affect Ad5-mediated
gene delivery (43). More recently, increasing evidence indi-
cates that actin-dependent endocytic events in the cell cortex
can also be regulated by calcium and PKC (38, 52). For exam-
ple, movement of intracellular vesicles containing avb3 inte-
grins seems to be affected by calcium (27), and calcium has
been implicated in endosomal fusion (10). Given our observa-
tions that three different inhibitors of classical PKCs, namely,
an ATP analogue (BIM), an effector site inhibitor (calphostin
C), and a PKCa pseudosubstrate mimicking the catalytic site
(PKC-myr peptide), all inhibited Ad escape from endosomes
without affecting virus endocytosis or fiber release, we specu-
late that a calcium-dependent classical PKC plays a role in
peripheral trafficking of endocytic vesicles containing Ad2. In
addition, our EM analysis indicated that the disruption of the
actin cytoskeleton gave rise to a modest number of small pe-
ripheral endocytic vesicles containing Ad2, which were indis-
tinguishable from those present in the PKC-inhibited cells.
Together, these results may suggest that cytosolic calcium can
be involved in Ad infection, despite the report that global
calcium influx does not occur during the first 10 to 15 min of
subgroup C Ad infections (43). It is, however, possible that
local increases in the concentration of cytosolic calcium, per-
haps in the vicinity of endocytic vesicles, are sufficient, together
with additional unknown factors, to execute the proper endo-
cytic trafficking and stimulate virus escape to the cytosol.
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